Article | January 15, 2020

The Critical Role Registries Play In Rare Diseases

Don Gabriel, MD, Ph.D. Sr. Director, Medical Oncology and Scientific Strategy, UBC and Colleen Valenzuela, MS Project Director, Clinical Operations, UBC

Doctor and patient

Rare diseases with single gene mutations are now showing great potential for treatment and, in some cases, even the potential for a cure. Certain cancers are also being treated using these techniques. New products are rapidly being introduced to the marketplace, and the number of early stage assets are expanding rapidly. Several different treatment approaches are used, but all strategies aim to target the correction of a mutated or missing gene.

UBC's Dr. Don Gabriel, Medical Oncology & Scientific Strategy and Colleen Valenzuela, Clinical Operations share their insights on the importance of registries in rare diseases.

 

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Cell & Gene? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: